CNO Financial (CNO)
Market Price (3/13/2026): $39.48 | Market Cap: $3.8 BilSector: Financials | Industry: Life & Health Insurance
CNO Financial (CNO)
Market Price (3/13/2026): $39.48Market Cap: $3.8 BilSector: FinancialsIndustry: Life & Health Insurance
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.6%, FCF Yield is 18% | Weak multi-year price returns3Y Excs Rtn is -1.4% | Key risksCNO key risks include [1] an acute earnings sensitivity to both high and low interest rate environments due to its specific liabilities from embedded derivatives and annuities. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -120% | ||
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15% | ||
| Low stock price volatilityVol 12M is 29% | ||
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Fintech & Digital Payments. Themes include Geriatric Care, Online Banking & Lending, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.6%, FCF Yield is 18% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -120% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15% |
| Low stock price volatilityVol 12M is 29% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Fintech & Digital Payments. Themes include Geriatric Care, Online Banking & Lending, Show more. |
| Weak multi-year price returns3Y Excs Rtn is -1.4% |
| Key risksCNO key risks include [1] an acute earnings sensitivity to both high and low interest rate environments due to its specific liabilities from embedded derivatives and annuities. |
Qualitative Assessment
AI Analysis | Feedback
1. Strong Q4 2025 Earnings Beat and Full-Year Performance.
CNO Financial reported robust financial results for the fourth quarter and full year 2025. The company's Q4 2025 operating earnings per share (EPS) reached $1.47, significantly surpassing the Zacks Consensus Estimate of $1.20, representing a 22.50% positive surprise. This strong quarterly performance contributed to a full-year 2025 operating EPS of $4.40, marking an 11% increase from the prior year. Additionally, Q4 2025 revenue of $1.17 billion exceeded the Zacks Consensus Estimate of $1.01 billion.
2. Consistent Sales Growth and Operational Momentum.
The company demonstrated sustained operational strength with its 14th consecutive quarter of strong insurance sales, achieving a record 15% growth in total new annualized premiums (NAP) for the full year 2025. This growth was observed across both its Consumer and Worksite divisions. Furthermore, client assets in brokerage and advisory services increased by 24% year-over-year, and the company reported continued growth in its producing agent count.
Show more
Stock Movement Drivers
Fundamental Drivers
The -2.0% change in CNO stock from 11/30/2025 to 3/12/2026 was primarily driven by a -29.6% change in the company's Net Income Margin (%).| (LTM values as of) | 11302025 | 3122026 | Change |
|---|---|---|---|
| Stock Price ($) | 40.59 | 39.77 | -2.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 4,442 | 4,487 | 1.0% |
| Net Income Margin (%) | 7.0% | 4.9% | -29.6% |
| P/E Multiple | 12.6 | 17.1 | 35.7% |
| Shares Outstanding (Mil) | 97 | 95 | 1.5% |
| Cumulative Contribution | -2.0% |
Market Drivers
11/30/2025 to 3/12/2026| Return | Correlation | |
|---|---|---|
| CNO | -2.0% | |
| Market (SPY) | -2.5% | 43.1% |
| Sector (XLF) | -8.4% | 70.7% |
Fundamental Drivers
The 2.1% change in CNO stock from 8/31/2025 to 3/12/2026 was primarily driven by a 32.4% change in the company's P/E Multiple.| (LTM values as of) | 8312025 | 3122026 | Change |
|---|---|---|---|
| Stock Price ($) | 38.97 | 39.77 | 2.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 4,382 | 4,487 | 2.4% |
| Net Income Margin (%) | 6.8% | 4.9% | -27.3% |
| P/E Multiple | 12.9 | 17.1 | 32.4% |
| Shares Outstanding (Mil) | 99 | 95 | 3.6% |
| Cumulative Contribution | 2.1% |
Market Drivers
8/31/2025 to 3/12/2026| Return | Correlation | |
|---|---|---|
| CNO | 2.1% | |
| Market (SPY) | 3.5% | 33.5% |
| Sector (XLF) | -9.3% | 67.4% |
Fundamental Drivers
The -2.6% change in CNO stock from 2/28/2025 to 3/12/2026 was primarily driven by a -47.9% change in the company's Net Income Margin (%).| (LTM values as of) | 2282025 | 3122026 | Change |
|---|---|---|---|
| Stock Price ($) | 40.81 | 39.77 | -2.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 4,446 | 4,487 | 0.9% |
| Net Income Margin (%) | 9.5% | 4.9% | -47.9% |
| P/E Multiple | 10.0 | 17.1 | 71.3% |
| Shares Outstanding (Mil) | 103 | 95 | 8.0% |
| Cumulative Contribution | -2.6% |
Market Drivers
2/28/2025 to 3/12/2026| Return | Correlation | |
|---|---|---|
| CNO | -2.6% | |
| Market (SPY) | 13.1% | 65.9% |
| Sector (XLF) | -5.4% | 78.1% |
Fundamental Drivers
The 65.8% change in CNO stock from 2/28/2023 to 3/12/2026 was primarily driven by a 292.4% change in the company's P/E Multiple.| (LTM values as of) | 2282023 | 3122026 | Change |
|---|---|---|---|
| Stock Price ($) | 23.99 | 39.77 | 65.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 3,577 | 4,487 | 25.5% |
| Net Income Margin (%) | 17.6% | 4.9% | -72.0% |
| P/E Multiple | 4.4 | 17.1 | 292.4% |
| Shares Outstanding (Mil) | 114 | 95 | 20.3% |
| Cumulative Contribution | 65.8% |
Market Drivers
2/28/2023 to 3/12/2026| Return | Correlation | |
|---|---|---|
| CNO | 65.8% | |
| Market (SPY) | 74.3% | 56.4% |
| Sector (XLF) | 43.0% | 75.6% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CNO Return | 10% | -2% | 25% | 36% | 16% | -6% | 101% |
| Peers Return | 8% | 22% | 16% | 32% | 1% | -7% | 89% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -1% | 80% |
Monthly Win Rates [3] | |||||||
| CNO Win Rate | 58% | 42% | 58% | 50% | 83% | 0% | |
| Peers Win Rate | 62% | 52% | 60% | 65% | 53% | 40% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| CNO Max Drawdown | -5% | -29% | -10% | -9% | -4% | -6% | |
| Peers Max Drawdown | -10% | -14% | -11% | -13% | -13% | -9% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -2% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: GL, AFL, UNM, PRI, KMPR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/12/2026 (YTD)
How Low Can It Go
| Event | CNO | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -39.8% | -25.4% |
| % Gain to Breakeven | 66.0% | 34.1% |
| Time to Breakeven | 525 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -54.2% | -33.9% |
| % Gain to Breakeven | 118.5% | 51.3% |
| Time to Breakeven | 231 days | 148 days |
| 2018 Correction | ||
| % Loss | -47.6% | -19.8% |
| % Gain to Breakeven | 90.7% | 24.7% |
| Time to Breakeven | 812 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -98.8% | -56.8% |
| % Gain to Breakeven | 8061.5% | 131.3% |
| Time to Breakeven | 2,899 days | 1,480 days |
Compare to GL, AFL, UNM, PRI, KMPR
In The Past
CNO Financial's stock fell -39.8% during the 2022 Inflation Shock from a high on 5/17/2021. A -39.8% loss requires a 66.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About CNO Financial (CNO)
AI Analysis | Feedback
A **Prudential** for pre-retiree and retiree insurance and annuities.
A **Lincoln Financial Group** specializing in insurance and annuities for middle-income seniors.
AI Analysis | Feedback
- Life Insurance: Provides financial protection to beneficiaries upon the policyholder's death.
- Supplemental Health Insurance: Offers coverage for specific health needs such as critical illness, accidents, or hospital stays, complementing major medical plans.
- Annuities: Provides a guaranteed stream of income, primarily for retirement savings and distribution.
AI Analysis | Feedback
CNO Financial Group, Inc. (CNO) is an insurance holding company that primarily sells its products directly to individuals rather than to other companies.
The company serves the following categories of individual customers:
-
Middle-income seniors and pre-retirees: This customer segment, primarily served by CNO's Bankers Life and Colonial Penn brands, seeks a range of products including life insurance, health insurance (such as Medicare supplement and long-term care), and annuities to manage healthcare costs, protect assets, and ensure financial security during retirement.
-
Working individuals: Through its Washington National brand, CNO serves working individuals who are often seeking supplemental health insurance products (such as critical illness, accident, and short-term disability) and basic life insurance. These products are frequently offered through employer-sponsored worksite marketing programs or directly to individuals.
AI Analysis | Feedback
- Tata Consultancy Services (TCS.NS)
- Ernst & Young LLP
- Wilton Re Ltd.
AI Analysis | Feedback
Gary C. Bhojwani, Chief Executive Officer
Gary C. Bhojwani became chief executive officer of CNO Financial Group on January 1, 2018, having previously served as president of the company from April 2016 through December 2017. Prior to joining CNO, Mr. Bhojwani was a member of the Board of Management of Allianz SE and chairman of Allianz of America, Allianz Life Insurance Company, and Fireman's Fund Insurance Company from 2012 to 2015. He was chief executive officer of Allianz Life Insurance Company of North America from 2007 through 2012 and president of Commercial Business, Fireman's Fund Insurance Company from 2004 to 2007. Mr. Bhojwani was also chief executive officer of Lincoln General Insurance Company from 2002 to 2004, and he founded and was chief executive officer of Avalon Risk Management from 1998 to 2002. He holds a Bachelor of Science degree in actuarial science from the University of Illinois and an MBA from the University of Chicago.
Paul H. McDonough, Chief Financial Officer
Paul H. McDonough was named chief financial officer for CNO Financial Group in March 2019. He brings nearly thirty years of public company finance and twenty years of insurance industry expertise to CNO. Prior to joining CNO, he served as executive vice president and chief financial officer of OneBeacon Insurance Group from 2005 to 2017, where he was instrumental in completing the company's successful IPO and executing a corporate restructuring. Previously, Mr. McDonough was chief financial officer at BJ's Wholesale Club in 2005 and held treasury roles at The St. Paul Companies from 1999 to 2004. He also worked in strategic planning and finance at Sears and Chevron, and proudly served as an officer in the U.S. Navy and Navy Reserve for six years. Mr. McDonough earned a bachelor's degree in government from Georgetown University and an MBA from the Kellogg Graduate School of Management at Northwestern University.
Karen J. DeToro, Chief Actuary and Chief Risk Officer
Karen J. DeToro has served as chief actuary of CNO Financial Group since September 2019 and was named chief risk officer in June 2020. Before joining CNO, DeToro held executive leadership positions in finance operations, product development, underwriting, strategy, and governance at New York Life, including serving as vice president and chief actuary of New York Life Direct. She was also a principal at Deloitte Consulting, where she led its Insurance Enterprise Risk Management (ERM) and Actuarial Transformation initiatives.
Eric R. Johnson, Chief Investment Officer and President, 40|86 Advisors, Inc.
Eric R. Johnson serves as the Chief Investment Officer of CNO Financial Group and President of 40|86 Advisors, Inc.
Joel Koehneman, Chief Accounting Officer
Joel Koehneman was appointed chief accounting officer of CNO Financial Group, effective January 25, 2025. He most recently served as a finance director at CDW Corporation. Mr. Koehneman has over 16 years of experience in the audit practice of PricewaterhouseCoopers (PwC), primarily focusing on life insurance clients, including serving as lead director on two life insurance company audits.
AI Analysis | Feedback
Here are the key risks to CNO Financial:
-
Interest Rate Fluctuations: CNO Financial is highly sensitive to changes in interest rates. A prolonged low interest rate environment can reduce the net spread between the interest earned on investments and the interest credited to policyholders, impacting profitability. Conversely, a prolonged high-rate environment could depress earnings, as the company's embedded derivatives and annuity liabilities are acutely sensitive to Federal Reserve policy. Interest rate changes also directly affect the value of CNO's investment portfolio and influence policyholder behavior.
-
Investment Portfolio Performance and Market Volatility: The company faces risks related to its investment portfolio, including potential unrealized losses that could pressure book value if interest rates rise further or credit quality deteriorates. Losses on investments can reduce the returns credited to customers, negatively affecting sales and financial performance. CNO's business is exposed to the performance of debt and equity markets, and adverse market conditions can impact the liquidity and value of its investments. Furthermore, persistent inflation poses risks to investment values.
-
General Economic Conditions and Regulatory Environment: As an insurance provider, CNO Financial is exposed to broader economic cycles and regulatory changes. General economic factors, such as credit availability, consumer spending, business investment, and inflation, can depress demand for insurance products, leading to higher policy lapses or surrenders during economic downturns. The company also faces challenges from regulatory compliance and potential changes in tax laws, which could impact its operations and financial stability.
AI Analysis | Feedback
The clear emerging threat to CNO Financial comes from the accelerating rise of digital-first, direct-to-consumer (DTC) platforms and Insurtech companies specifically targeting the middle-income pre-retiree and retiree market for life, health, and annuity products. These emerging competitors leverage advanced digital marketing, artificial intelligence, and streamlined online application processes to offer a potentially lower-cost and more convenient alternative to CNO's traditional agent-centric (Bankers Life) and traditional direct-response (Colonial Penn) distribution models. This shift directly challenges CNO's established distribution advantages by appealing to an increasingly digitally savvy older demographic, threatening to erode market share and pricing power through more efficient customer acquisition and reduced overhead.
AI Analysis | Feedback
| Product/Service | Addressable Market Size | Region |
|---|---|---|
| Health Insurance (Overall U.S.) | USD 1.57 trillion (2025) | U.S. |
| Medicare Supplement Health Insurance | USD 39.1 billion (2024) | U.S. |
| Long-Term Care Private Insurance | USD 25.6 billion (2025) | U.S. |
| Life Insurance | USD 1.46 trillion (2024) | U.S. |
| Annuities | Over USD 430 billion (2024) | U.S. |
| Financial Services (Wealth Management Solutions) | null | null |
| Workforce Benefits Solutions | null | null |
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for CNO Financial (symbol: CNO) over the next 2-3 years:- Sustained Sales Momentum in Consumer and Worksite Divisions: CNO Financial anticipates continued robust growth in new annualized premiums across both its Consumer and Worksite Divisions. This includes strong performance in direct-to-consumer life insurance sales, which have seen significant surges, and consistent increases in Worksite Life and Health New Annualized Premiums. The company's strategic focus on the middle-income market further underpins this growth.
- Expansion of Annuity and Financial Advisory Products: Growth in collected annuity premiums and client assets in brokerage and advisory services is expected to contribute to revenue expansion. CNO Financial has demonstrated a consistent upward trend in these areas, reflecting strong demand for retirement and financial planning solutions.
- Product Innovation and Enhanced Offerings: CNO Financial is committed to launching innovative products and improving its existing portfolio. This strategy aims to capture future insurance premium growth by meeting evolving customer needs, as exemplified by the introduction and anticipated improvement in products like Optavise Clear, which bundles existing services with new Medicare advocacy and improved technology.
- Strategic Repositioning through Bermuda Treaty and Business Exit: The execution of a second Bermuda treaty and the strategic exit from the Worksite fee services business are expected to accelerate operating return on equity (ROE) improvement. While not a direct revenue driver, this streamlining and enhanced capital efficiency allow the company to sharpen its focus on higher-growth, more profitable core insurance offerings, indirectly supporting revenue growth.
- Favorable Demographic Trends: An aging U.S. population presents a significant tailwind for CNO Financial. The increasing number of Americans entering retirement age drives strong demand for the company's diversified product portfolio, which includes annuity, health, and life insurance offerings catering to the growing needs of the middle-income market.
AI Analysis | Feedback
Share Repurchases
- CNO Financial repurchased $60.0 million of common stock in Q3 2025, buying 1.6 million shares at an average cost of $38.19 per share.
- As of September 30, 2025, the company had authority to repurchase up to an additional $480.4 million of common stock.
- In Q2 2025, CNO repurchased $100 million in shares, contributing to a year-to-date total of $234 million in shareholder returns, and had an authorization of approximately $540.4 million remaining as of June 30, 2025.
- For the full year 2024, CNO returned $349 million to shareholders, a 50% increase from 2023. In February 2025, the Board approved an additional $500 million for share repurchases, adding to the $240.3 million remaining capacity as of December 31, 2024.
- In 2023, CNO returned more than $230 million to shareholders.
- In 2022, CNO returned $245 million to shareholders in the form of share repurchases and dividends, with $10.0 million in share repurchases in Q4 2022.
- In 2021, the company returned $468.1 million to shareholders, which included a record $402.4 million in share repurchases. In May 2021, an additional $500 million was approved for share repurchases, adding to approximately $169 million remaining capacity as of March 31, 2021.
- In 2020, CNO repurchased 14.5 million shares for $263.0 million, and had remaining repurchase authority of $269.3 million as of December 31, 2020.
Share Issuance
- As of September 30, 2025, CNO Financial had 95.8 million shares outstanding. This is a decrease from 98.6 million weighted average diluted shares outstanding in Q3 2025.
- Weighted average diluted shares outstanding decreased by 7% from Q4 2021 to Q4 2022.
Outbound Investments
- In October 2025, CNO decided to streamline its Worksite Division operations by exiting the fee services side of the business, which included services acquired in the Web Benefits Design and DirectPath acquisitions. This exit is expected to be substantially complete in the first half of 2026.
Capital Expenditures
- CNO generally balances growth investments and technology expenditures against operating efficiency. The company continues to invest in technology and sales tools to support operational efficiency.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to CNO.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | NDAQ | Nasdaq | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | JEF | Jefferies Financial | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | PAYO | Payoneer Global | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02272026 | FOUR | Shift4 Payments | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02202026 | COIN | Coinbase Global | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 2.6% | 2.6% | -6.5% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 91.16 |
| Mkt Cap | 9.5 |
| Rev LTM | 5,389 |
| Op Inc LTM | - |
| FCF LTM | 775 |
| FCF 3Y Avg | 896 |
| CFO LTM | 794 |
| CFO 3Y Avg | 977 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.4% |
| Rev Chg 3Y Avg | 3.9% |
| Rev Chg Q | 1.9% |
| QoQ Delta Rev Chg LTM | 0.5% |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | 14.9% |
| CFO/Rev 3Y Avg | 14.8% |
| FCF/Rev LTM | 14.9% |
| FCF/Rev 3Y Avg | 14.8% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 9.5 |
| P/S | 1.4 |
| P/EBIT | 8.3 |
| P/E | 13.8 |
| P/CFO | 8.4 |
| Total Yield | 9.9% |
| Dividend Yield | 1.9% |
| FCF Yield 3Y Avg | 9.3% |
| D/E | 0.3 |
| Net D/E | -1.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -5.2% |
| 3M Rtn | -2.6% |
| 6M Rtn | -2.2% |
| 12M Rtn | -0.3% |
| 3Y Rtn | 74.3% |
| 1M Excs Rtn | -2.8% |
| 3M Excs Rtn | 0.9% |
| 6M Excs Rtn | -3.7% |
| 12M Excs Rtn | -22.3% |
| 3Y Excs Rtn | -13.8% |
Segment Financials
Assets by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Annuity | 13,006 | 12,006 | 10,971 | 13,289 | 13,074 |
| Investments not allocated to product lines | 10,598 | 8,712 | 8,857 | 7,093 | 6,426 |
| Health | 9,117 | 9,512 | 9,020 | 10,559 | 10,931 |
| Life | 4,195 | 4,154 | 3,784 | 4,686 | 4,422 |
| Assets of our other non-life companies | 680 | 399 | 293 | 384 | 371 |
| Assets of our non-life companies included in the fee income segment | 258 | 244 | 208 | 194 | 117 |
| Total | 37,853 | 35,027 | 33,133 | 36,204 | 35,340 |
Price Behavior
| Market Price | $39.77 | |
| Market Cap ($ Bil) | 3.8 | |
| First Trading Date | 09/10/2003 | |
| Distance from 52W High | -10.5% | |
| 50 Days | 200 Days | |
| DMA Price | $42.07 | $39.59 |
| DMA Trend | up | up |
| Distance from DMA | -5.5% | 0.5% |
| 3M | 1YR | |
| Volatility | 26.0% | 28.6% |
| Downside Capture | 66.68 | 89.18 |
| Upside Capture | 62.01 | 75.78 |
| Correlation (SPY) | 43.4% | 65.8% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.40 | 1.26 | 1.08 | 0.67 | 0.99 | 1.03 |
| Up Beta | 3.48 | 3.37 | 3.12 | 1.63 | 1.02 | 1.08 |
| Down Beta | 1.23 | 1.16 | 1.05 | 0.59 | 1.18 | 1.08 |
| Up Capture | 108% | 59% | 60% | 45% | 65% | 93% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 13 | 20 | 32 | 70 | 140 | 406 |
| Down Capture | 62% | 81% | 48% | 43% | 91% | 99% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 8 | 20 | 28 | 52 | 109 | 338 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CNO | |
|---|---|---|---|---|
| CNO | 4.0% | 28.5% | 0.13 | - |
| Sector ETF (XLF) | 3.6% | 19.3% | 0.06 | 77.7% |
| Equity (SPY) | 21.0% | 18.9% | 0.87 | 65.7% |
| Gold (GLD) | 74.9% | 26.2% | 2.12 | -4.0% |
| Commodities (DBC) | 19.3% | 17.2% | 0.89 | 18.9% |
| Real Estate (VNQ) | 5.7% | 16.3% | 0.16 | 58.1% |
| Bitcoin (BTCUSD) | -16.1% | 44.2% | -0.27 | 25.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CNO | |
|---|---|---|---|---|
| CNO | 12.7% | 28.9% | 0.44 | - |
| Sector ETF (XLF) | 9.5% | 18.7% | 0.39 | 75.3% |
| Equity (SPY) | 13.2% | 17.0% | 0.61 | 57.0% |
| Gold (GLD) | 24.2% | 17.3% | 1.14 | 1.6% |
| Commodities (DBC) | 10.9% | 19.0% | 0.46 | 16.0% |
| Real Estate (VNQ) | 5.0% | 18.8% | 0.17 | 48.3% |
| Bitcoin (BTCUSD) | 7.3% | 56.8% | 0.35 | 17.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CNO | |
|---|---|---|---|---|
| CNO | 10.5% | 34.5% | 0.38 | - |
| Sector ETF (XLF) | 12.5% | 22.2% | 0.52 | 80.3% |
| Equity (SPY) | 14.7% | 17.9% | 0.70 | 66.7% |
| Gold (GLD) | 14.6% | 15.6% | 0.77 | -3.0% |
| Commodities (DBC) | 8.8% | 17.6% | 0.41 | 26.0% |
| Real Estate (VNQ) | 5.5% | 20.7% | 0.23 | 56.5% |
| Bitcoin (BTCUSD) | 66.7% | 66.8% | 1.06 | 15.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/5/2026 | 5.5% | 2.1% | -2.3% |
| 11/3/2025 | 4.3% | 3.3% | 1.8% |
| 7/28/2025 | -1.6% | -4.6% | 4.4% |
| 4/28/2025 | -4.8% | -6.4% | -6.2% |
| 2/6/2025 | 2.6% | 3.7% | -3.1% |
| 10/31/2024 | 4.4% | 12.0% | 14.4% |
| 7/29/2024 | 10.7% | 2.1% | 9.2% |
| 4/29/2024 | -2.1% | 3.0% | 2.7% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 12 | 14 |
| # Negative | 11 | 12 | 10 |
| Median Positive | 2.8% | 2.6% | 7.8% |
| Median Negative | -4.0% | -2.7% | -6.4% |
| Max Positive | 10.7% | 12.1% | 20.5% |
| Max Negative | -11.0% | -12.6% | -14.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/24/2026 | 10-K |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 02/26/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/06/2024 | 10-Q |
| 12/31/2023 | 02/23/2024 | 10-K |
| 09/30/2023 | 11/08/2023 | 10-Q |
| 06/30/2023 | 08/09/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 02/24/2023 | 10-K |
| 09/30/2022 | 11/04/2022 | 10-Q |
| 06/30/2022 | 08/05/2022 | 10-Q |
| 03/31/2022 | 05/06/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bhojwani, Gary C | Chief Executive Officer | Direct | Sell | 1022026 | 41.99 | 31,430 | 1,319,639 | 8,226,267 | Form |
| 2 | Tarasi, Rocco F Iii | Chief Marketing Officer | Direct | Sell | 12152025 | 42.60 | 9,283 | 395,439 | 3,149,367 | Form |
| 3 | Franzese, Yvonne K | Chief Human Resources Officer | Direct | Sell | 11252025 | 41.00 | 3,000 | 123,000 | 886,297 | Form |
| 4 | Bhojwani, Gary C | Chief Executive Officer | Direct | Sell | 11212025 | 39.97 | 31,430 | 1,256,342 | 9,088,033 | Form |
| 5 | Johnson, Eric R | Chief Investment Officer | Direct | Sell | 11132025 | 41.24 | 48,665 | 2,007,013 | 27,695,332 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Life & Health Insurance Resources |
| Insurance Business America |
| A.M. Best |
| National Underwriter |
| Insurance News |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.